To determine whether HER2 was amplified in other available cervical cancer cell lines (i.e., HeLa, SiHa, ME-180, MS751, and Caski), we analyzed the HER2 copy number by quantitative polymerase chain reaction (qPCR). The gene discussed is ERBB2; the disease is cervical cancer.